DPP-4 inhibitor and alpha-glucosidase inhibitor equally improve endothelial function in patients with type 2 diabetes: EDGE study

BACKGROUND: Alpha glucosidase inhibitor (GI) attenuates postprandial hyperglycemia (PPH) and reduces the risk of cardiovascular events in patients with impaired glucose tolerance or type 2 diabetes. Dipeptidyl peptidase 4 (DPP-4) inhibitors also attenuate PPH. PPH is one of the factors leading to en...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Kazufumi, Oe, Hiroki, Kihara, Hajime, Shimada, Kenei, Fukuda, Shota, Watanabe, Kyoko, Takagi, Tsutomu, Yunoki, Kei, Miyoshi, Toru, Hirata, Kumiko, Yoshikawa, Junichi, Ito, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149239/
https://www.ncbi.nlm.nih.gov/pubmed/25074318
http://dx.doi.org/10.1186/s12933-014-0110-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149239/
https://www.ncbi.nlm.nih.gov/pubmed/25074318
http://dx.doi.org/10.1186/s12933-014-0110-2

Ejemplares similares